Sugi Predict

Sugi Predict / Compounds / SCHEMBL6318967

SCHEMBL6318967

SCHEMBL6318967

CN(C(=O)CCNC(=O)OC(C)(C)C)c1ccc(N/C(=C2\C(=O)Nc3ccccc32)c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MALT1 Q9UDY8 1/20 0.38
▸ IDO1 P14902 2/20 0.37
▸ TDO2 P48775 1/20 0.37
▸ MAPK10 P53779 1/20 0.35
▸ NAMPT P43490 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ CREBBP Q92793 1/20 0.35
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ AKT1 P31749 1/20 0.33
▸ GBA1 P04062 1/20 0.33
▸ TPSAB1 Q15661 1/20 0.33
▸ TPSD1 Q9BZJ3 1/20 0.33
▸ TPSG1 Q9NRR2 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ FPR3 P25089 1/20 0.33
▸ FPR2 P25090 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6399909 1.00 MALT1 (0.38) MALT1IDO1TDO2MAPK10NAMPT
SCHEMBL6320532 0.88 IDO1 (0.38) IDO1TDO2TDP1
SCHEMBL6320537 0.88 IDO1 (0.38) IDO1TDO2TDP1
Hydrochloric Acid SCHEMBL6327524 0.83 IDO1 (0.40) IDO1TDO2CA1CA2TDP1
SCHEMBL6321667 0.83 IDO1 (0.40) IDO1TDO2TDP1
SCHEMBL6321660 0.83 IDO1 (0.40) IDO1TDO2TDP1
Hydrochloric Acid SCHEMBL6327527 0.83 IDO1 (0.40) IDO1TDO2CA1CA2TDP1
SCHEMBL6327047 0.83 IDO1 (0.41) IDO1TDO2CA1CA2TDP1
SCHEMBL6326191 0.83 IDO1 (0.41) IDO1TDO2CA1CA2TDP1
SCHEMBL6321171 0.83 BRD4 (0.47) IDO1TDO2MAPK10NAMPTBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6855710-B2 Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-02-15 — — US disclosed
US-20050025795-A1 Compounds, Compositions and methods for insect control THE PROCTER & GAMBLE COMPANY (US) 2005-02-03 — — US disclosed
US-20040058978-A1 Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-03-25 — — US disclosed
EP-1115704-B1 NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-06-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050025795-A1 Compounds, Compositions and methods for insect control PWWP2B, CUTA, WAPL MALT1 875/4885IDO1 3897/4885TDO2 1747/4885
US-20040058978-A1 Novel substituted indolines with an inhibitory effect on various kinases and complexes of CDKs CDK1, CDK2, CDK3 MALT1 1262/4885IDO1 232/4885TDO2 762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.